Found: 108
Select item for more details and to access through your institution.
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69382-8
- By:
- Publication type:
- Article
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1347547
- By:
- Publication type:
- Article
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 962, doi. 10.1002/cncr.35109
- By:
- Publication type:
- Article
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 576, doi. 10.1111/bjh.19067
- By:
- Publication type:
- Article
Position paper: The time for cooperative group study of ropeginterferon alfa‐2b in young patients with myeloproliferative neoplasms is now.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 10, p. 1, doi. 10.1002/pbc.30559
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30584
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30584
- By:
- Publication type:
- Article
Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 8, p. 1352, doi. 10.1111/cts.13539
- By:
- Publication type:
- Article
Machine learning classifier approaches for predicting response to RTK-type-III inhibitors demonstrate high accuracy using transcriptomic signatures and ex vivo data.
- Published in:
- Bioinformatics Advances, 2023, v. 3, n. 1, p. 1, doi. 10.1093/bioadv/vbad034
- By:
- Publication type:
- Article
Evaluation of the pan‐class I phosphoinositide 3‐kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 1, p. 1, doi. 10.1002/pbc.30017
- By:
- Publication type:
- Article
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100072
- By:
- Publication type:
- Article
Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 1, p. 1, doi. 10.1002/pbc.29313
- By:
- Publication type:
- Article
Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 12, p. 1, doi. 10.1002/pbc.29281
- By:
- Publication type:
- Article
Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 789, doi. 10.3390/cancers13040789
- By:
- Publication type:
- Article
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring.
- Published in:
- BMC Medical Genomics, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s12920-020-0671-8
- By:
- Publication type:
- Article
Stability and change in family psychosocial risk over 6 months in pediatric cancer and its association with medical and psychosocial healthcare utilization.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A psychosocial clinical care pathway for pediatric hematopoietic stem cell transplantation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bone marrow transplant and pediatric multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Delivery of care consistent with the psychosocial standards in pediatric cancer: Current practices in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Opportunities for expanding clinical trial enrollment for relapsed and refractory pediatric acute myeloid leukemia in the United States and Canada.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Implementing the psychosocial standards in pediatric cancer: Current staffing and services available.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00042
- By:
- Publication type:
- Article
Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Generation of Pediatric Leukemia Xenograft Models In NSG-B2m Mice: Comparison with NOD/SCID Mice.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00162
- By:
- Publication type:
- Article
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142704
- By:
- Publication type:
- Article
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140564
- By:
- Publication type:
- Article
Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 6, p. 1106, doi. 10.1002/pbc.25329
- By:
- Publication type:
- Article
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: A Children's Oncology Group Phase I Consortium report.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 5, p. 751, doi. 10.1002/pbc.25464
- By:
- Publication type:
- Article
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 1, p. 91, doi. 10.1002/pbc.25201
- By:
- Publication type:
- Article
Initial solid tumor testing (Stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing program.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 11, p. 1972, doi. 10.1002/pbc.25175
- By:
- Publication type:
- Article
Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 10, p. 1816, doi. 10.1002/pbc.25099
- By:
- Publication type:
- Article
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 8, p. 1486, doi. 10.1002/pbc.24989
- By:
- Publication type:
- Article
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 8, p. 1493, doi. 10.1002/pbc.25026
- By:
- Publication type:
- Article
Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0106249
- By:
- Publication type:
- Article
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 2, p. 245, doi. 10.1002/pbc.24724
- By:
- Publication type:
- Article